- Home
- GTEC vs CRIS Comparison
GTEC vs CRIS Comparison
Compare GTEC & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTEC
- CRIS
- Stock Information
- Founded
- GTEC 2006
- CRIS 2000
- Country
- GTEC United States
- CRIS United States
- Employees
- GTEC N/A
- CRIS N/A
- Industry
- GTEC Industrial Machinery/Components
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GTEC Industrials
- CRIS Health Care
- Exchange
- GTEC Nasdaq
- CRIS Nasdaq
- Market Cap
- GTEC 19.7M
- CRIS 21.3M
- IPO Year
- GTEC N/A
- CRIS 2000
- Fundamental
- Price
- GTEC $1.97
- CRIS $2.32
- Analyst Decision
- GTEC
- CRIS Strong Buy
- Analyst Count
- GTEC 0
- CRIS 2
- Target Price
- GTEC N/A
- CRIS $16.50
- AVG Volume (30 Days)
- GTEC 103.9K
- CRIS 71.8K
- Earning Date
- GTEC 08-14-2025
- CRIS 07-31-2025
- Dividend Yield
- GTEC N/A
- CRIS N/A
- EPS Growth
- GTEC N/A
- CRIS N/A
- EPS
- GTEC 1.14
- CRIS N/A
- Revenue
- GTEC $82,898,634.00
- CRIS $11,202,000.00
- Revenue This Year
- GTEC $3.28
- CRIS N/A
- Revenue Next Year
- GTEC N/A
- CRIS $10.67
- P/E Ratio
- GTEC $1.74
- CRIS N/A
- Revenue Growth
- GTEC N/A
- CRIS 14.17
- 52 Week Low
- GTEC $1.17
- CRIS $1.02
- 52 Week High
- GTEC $2.94
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- GTEC 51.66
- CRIS 52.52
- Support Level
- GTEC $2.01
- CRIS $2.11
- Resistance Level
- GTEC $2.26
- CRIS $2.26
- Average True Range (ATR)
- GTEC 0.09
- CRIS 0.21
- MACD
- GTEC -0.01
- CRIS -0.04
- Stochastic Oscillator
- GTEC 38.87
- CRIS 21.36
About GTEC Greenland Technologies Holding Corporation
Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.